Metabolic Disorders

Jul 20, 2021| Posted in: Congenital And Genetic Conditions, Metabolic Disorders

FDA Approves Odevixibat, First Drug Therapy for PFIC

The Food and Drug Administration (FDA) has approved…

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.
  • Heather Lau, MD, MS, NYU School of Medicine, New York, NY
  • Morie A Gertz, MD, Mayo Clinic, Rochester, MN
  • Timothy Craig, DO, Penn State University, Hershey, PA
  • Eric T. Wong, MD, Harvard Medical School, Boston, MA

Metabolic Disorders